Bayer sells animal health division for $7.6 billion, denies deal prompted by glyphosate-cancer lawsuits

s reutersmedia net
Credit: Reuters

Agriculture and pharmaceutical giant Bayer [August 20] agreed [to] a $7.6 billion deal to sell its animal health business to U.S.-based animal health company Elanco …. The deal with Elanco means Bayer will now no longer make products that prevent and treat diseases in farm animals and pets.

Bayer finds itself in a tough political situation after its $63 billion acquisition of glyphosate-maker Monsanto last year. Having taken on the liability for the controversial weedkiller, Bayer has been facing a wave of claims from plaintiffs saying glyphosate caused their cancer …. Bayer …. denied any link between the glyphosate lawsuits and the animal health sell-off.

Read full, original article: Bayer sells animal health business (Behind paywall)

{{ reviewsTotal }}{{ options.labels.singularReviewCountLabel }}
{{ reviewsTotal }}{{ options.labels.pluralReviewCountLabel }}
{{ options.labels.newReviewButton }}
{{ userData.canReview.message }}
skin microbiome x final

Infographic: Could gut bacteria help us diagnose and treat diseases? This is on the horizon thanks to CRISPR gene editing

Humans are never alone. Even in a room devoid of other people, they are always in the company of billions ...
glp menu logo outlined

Newsletter Subscription

* indicates required
Email Lists
glp menu logo outlined

Get news on human & agricultural genetics and biotechnology delivered to your inbox.